Romanelli Joseph 4
4 · Merck & Co., Inc. · Filed May 2, 2025
Insider Transaction Report
Form 4
Romanelli Joseph
President, Human Health Int?l
Transactions
- Exercise/Conversion
Common Stock
2025-05-02$83.26/sh+2,262$188,334→ 24,060.545 total - Exercise/Conversion
Common Stock
2025-04-30$84.71/sh+2,063$174,757→ 22,815.545 total - Tax Payment
Common Stock
2025-04-30$84.71/sh−1,017$86,150→ 21,798.545 total - Tax Payment
Common Stock
2025-05-02$83.26/sh−1,115$92,835→ 22,945.545 total - Exercise/Conversion
Restricted Stock Unit
2025-04-30−2,063→ 4,128 totalFrom: 2025-04-30Exp: 2027-04-30→ Common Stock (2,063 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-05-02−2,262→ 2,262 totalFrom: 2024-05-02Exp: 2026-05-02→ Common Stock (2,262 underlying)
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.